4//SEC Filing
Cahill Thomas 4
Accession 0001628280-22-027122
CIK 0001894562other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 8:00 PM ET
Size
11.8 KB
Accession
0001628280-22-027122
Insider Transaction Report
Form 4
Cahill Thomas
Director
Transactions
- Conversion
Common Stock
2022-10-24+4,905,679→ 4,905,679 total(indirect: By Newpath Partners, L.P.) - Purchase
Common Stock
2022-10-24$17.00/sh+400,000$6,800,000→ 5,305,679 total(indirect: By Newpath Partners, L.P.) - Conversion
Series A Convertible Preferred Stock
2022-10-24−9,999,999→ 0 total(indirect: By Newpath Partners, L.P.)→ Common Stock (3,216,674 underlying) - Conversion
Series B Convertible Preferred Stock
2022-10-24−5,250,781→ 0 total(indirect: By Newpath Partners, L.P.)→ Common Stock (1,689,005 underlying)
Footnotes (3)
- [F1]The shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (together, the "Preferred Stock") were convertible into Common Stock on a one-for-3.10880 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on October 24, 2022. The Preferred Stock had no expiration date.
- [F2]Represents shares held directly by Newpath Partners, L.P. ("Newpath LP"). Newpath Partners GP, L.P. ("Newpath GP LP") is the general partner of Newpath LP. Newpath Partners GP, LLC ("Newpath GP LLC") is the general partner of Newpath GP LP. The Reporting Person is a managing member of Newpath GP LLC, and disclaims beneficial ownership of the shares held directly by Newpath LP except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
- [F3]Reflects shares purchased by Newpath LP in the Issuer's initial public offering.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001922939
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 8:00 PM ET
- Size
- 11.8 KB